Chinese “Pfizer vaccine, it is not an atomic bomb that will win the war”… The number of victories against the US through vaccination mobilization

Citizens sit waiting for their turn on the 3rd at a temporary inoculation center for the Corona 19 vaccine in Beijing, the capital of China. Beijing = AFP Yonhap News

“The vaccine alone cannot win the war against Corona. Mobilization is the key.”

China hit the game again. The opponent is the eternal rival America. Both countries have secured the weapon of vaccines. It is similar to the declaration of war against the novel coronavirus infection (Corona 19). Success or failure depends on who gets to’group immunity’ faster. This is the reason why China, which carries out the “inoculation task,” all at once, is confident of winning against the US, which is creaking everywhere.

China, 50 million vaccinations before Lunar New Year holidays

Citizens line up in front of the shuttle bus running from Beijing, China to the corona 19 vaccination center on the 4th. Beijing = AFP Yonhap News

The size of the vaccine vaccination against Corona 19 is similar, with 4.65 million people in the United States (as of 4 days) and 4.5 million people in China (as of the 31st of last month). Considering that about 75% of the population needs to be vaccinated to form collective immunity, China, which has a much larger population, can be considered to be later than the United States.

But China is fierce. 3 million people have been vaccinated in 15 days since the local vaccine was approved on the 15th of last month, and it is planned to increase to 50 million before the Lunar New Year holiday in early next month. In the capital Beijing alone, more than 73,000 people were vaccinated at 220 inoculation centers in one or two days. In Henan and other provinces, teams are formed to promote vaccination and encourage residents.

Graphic = Reporter Moon Joong Kim

The quantity is sufficient. The annual vaccine production of Sinofarm, the number one in the industry, reaches 1 billion doses. In contrast to the noisy controversy over the’split’ controversy in the US, where the vaccine is insufficient and half the dose is administered. Unlike the United States, where the vaccination rate is only 30% of the vaccine distributed by the federal government, and the hands and feet do not fit, China is taking a step forward by actively considering expanding the number of vaccination targets to the elderly and minors aged 60 or older.

China has an edge over the US national system…Strong in mobilizing society

At Zuisi Hospital on Long Island, Queens, New York City, nurse Sandra Lindsay is receiving Pfizer’s COVID-19 vaccine twice on the 14th of last month (pictured above) and the 4th of this month. Lindsay is the first COVID-19 vaccine in the United States. New York = Reuters Yonhap News

In response, China boasted of its superiority by shaving down, saying, “The US has collapsed the national system to face the crisis.” The difference between the two countries is remarkable in the ability to allocate and mobilize resources essential to coping with infectious diseases.

“When the Pfizer vaccine came out, the United States considered it as an aircraft carrier or atomic bomb that would bring victory in the war, but the reality is different,” said Hwangu Times reported on the 5th. . He then presented the views of public health experts that the number of Corona 19 deaths in the United States could increase by 200,000 by April 1. Although he is still suffering from sporadic infections, the number of deaths remains unchanged, which means that he is an actor in China, where the situation is relatively stable.

Graphic = Reporter Moon Joong Kim

Wang Qinghua, chief immunologist at the China Centers for Disease Control and Prevention, said, “It is the duty of all citizens to participate in high-volume vaccinations and a strong signal that will strengthen China’s hard-earned success in the fight against infectious diseases.”

China-made vaccine safety battles with Taiwan

At Ashibadem Hospital in Istanbul, Turkey, a nurse (center) in the presence of a specialist on the 21st of last month is injecting a volunteer into a volunteer for a phase 3 clinical trial of the Corona 19 vaccine produced by Sinovac, China. Istanbul = AP Yonhap News

The blind spot in China is the safety of the vaccine. A survey found that 25% of the people do not believe in vaccines. There are cases of making excuses for underlying diseases to avoid vaccination.

Finally, Taiwan came out. On the 31st of last month, the Taiwan Continental Committee, which is in charge of China’s affairs, demanded, “Beware of the dangers of Chinese vaccines,” and “do not target the Taiwanese people for vaccine testing.” It protested that Taiwanese residents living in the mainland were included in China’s preferred recipients.

China revolted strongly. State Council spokesman Zhu Fenglian issued a statement and refuted that “Taiwan has shown political malicious intent by slandering Chinese vaccines.” He said, “This vaccination is entirely out of love for Taiwanese compatriots,” he explained. “It is up to each person to choose whether to get the vaccine.”

Beijing= Kwangsoo Kim Correspondent

You can also view the news Naver Et edited by the Hankook Ilbo.
Subscribe on Newsstand


.Source